Risk factors

MBS item for FH cascade testing will promote early use of lipid lowering therapies

MBS items are now available for Familial Hypercholesterolemia (FH) genetic testing of affected individuals and cascade testing of their first and second degree relatives. The move is likely to help lipid clinics identify the many asymptomatic family members with FH who will benefit from early initiation of lipid lowering therapy, according to atherosclerosis specialists. “The ...

Already a member?

Login to keep reading.

© 2021 the limbic